Please login to the form below

Not currently logged in
Email:
Password:

Eric Green named NIH's data science lead

Takes role on interim basis as part of expanding plans for data

Dr Eric Green, NIHDr Eric Green, current director of the National Human Genome Research Institue (NHGRI), is to serve as the first associate director for data science at the US National Institutes for Health (NIH).

Dr Green takes the role on an interim basis while the NIH attempts to find someone to take on the position on a permanent basis to lead its efforts to expand in health informatics.

NIH director Dr Francis Collins said: "There is an urgent need and increased opportunities for advanced collaboration and coordination of access to, and analysis of, the rapidly expanding collections of biomedical data.”

"NIH aims to play a catalytic lead role in addressing these complex issues — not only internally, but also with stakeholders in the research community, other government agencies, and private organisations involved in scientific data generation, management and analysis."

Current data-related projects the NIH is involved in include the funding of national centres of biomedical computing, part of which have been spun-out to create an international public-private pharmaceutical and genomic research project, called tranSMART.

This project offers a data repository with demographics, clinical observations, clinical trial outcomes, adverse events and biomarker data like gene expression and metabolism.

Dr Green has been director of the NHGRI since 2009, having previously served as scientific director of the Institute and director of the NIH Intramural Sequencing Center (NISC).

22nd January 2013

From: Research, Healthcare

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

EU health fund
An EU emergency health fund to limit the impact of future crises
Leading finance experts propose an Emergency Health Financing Facility to limit the impact of future crises on the EU...
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...

Infographics